These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21830867)

  • 1. Role of genetic variation in the human sodium-glucose cotransporter 2 gene (SGLT2) in glucose homeostasis.
    Enigk U; Breitfeld J; Schleinitz D; Dietrich K; Halbritter J; Fischer-Rosinsky A; Enigk B; Müller I; Spranger J; Pfeiffer A; Stumvoll M; Kovacs P; Tönjes A
    Pharmacogenomics; 2011 Aug; 12(8):1119-26. PubMed ID: 21830867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations.
    Ordelheide AM; Böhm A; Kempe-Teufel D; Wagner R; Machicao F; Heni M; Stefan N; Fritsche A; Häring HU; Staiger H
    PLoS One; 2017; 12(5):e0177148. PubMed ID: 28472182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved glycemic control in mice lacking Sglt1 and Sglt2.
    Powell DR; DaCosta CM; Gay J; Ding ZM; Smith M; Greer J; Doree D; Jeter-Jones S; Mseeh F; Rodriguez LA; Harris A; Buhring L; Platt KA; Vogel P; Brommage R; Shadoan MK; Sands AT; Zambrowicz B
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E117-30. PubMed ID: 23149623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits].
    Xiang K; Fang Q; Zheng T; Jia W; Wang Y; Zhang R; Li J; Shen K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):426-30. PubMed ID: 11774208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes?
    Tönjes A; Kovacs P
    Pharmacogenomics; 2013 May; 14(7):825-33. PubMed ID: 23651029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis.
    Drexel H; Leiherer A; Saely CH; Brandtner EM; Geiger K; Vonbank A; Fraunberger P; Muendlein A
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 30988077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.
    DeFronzo RA; Davidson JA; Del Prato S
    Diabetes Obes Metab; 2012 Jan; 14(1):5-14. PubMed ID: 21955459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.
    Müssig K; Staiger H; Machicao F; Stancáková A; Kuusisto J; Laakso M; Thamer C; Machann J; Schick F; Claussen CD; Stefan N; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1353-60. PubMed ID: 19141580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.
    Kurosaki E; Ogasawara H
    Pharmacol Ther; 2013 Jul; 139(1):51-9. PubMed ID: 23563279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.
    Jabbour SA
    Postgrad Med; 2014 Jan; 126(1):111-7. PubMed ID: 24393758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion.
    Rose CS; Andersen G; Hamid YH; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
    Diabet Med; 2005 Jul; 22(7):946-9. PubMed ID: 15975113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.
    Powell DR; Smith M; Greer J; Harris A; Zhao S; DaCosta C; Mseeh F; Shadoan MK; Sands A; Zambrowicz B; Ding ZM
    J Pharmacol Exp Ther; 2013 May; 345(2):250-9. PubMed ID: 23487174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population.
    Romeo S; Sentinelli F; Cavallo MG; Leonetti F; Fallarino M; Mariotti S; Baroni MG
    Int J Obes (Lond); 2008 Mar; 32(3):413-20. PubMed ID: 17912268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study.
    Bonfigli AR; Sirolla C; Testa R; Cucchi M; Spazzafumo L; Salvioli S; Ceriello A; Olivieri F; Festa R; Procopio AD; Brandoni G; Boemi M; Marra M; Franceschi C
    Acta Diabetol; 2013 Jun; 50(3):429-36. PubMed ID: 23269546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects.
    Zambrowicz B; Ogbaa I; Frazier K; Banks P; Turnage A; Freiman J; Boehm KA; Ruff D; Powell D; Sands A
    Clin Ther; 2013 Aug; 35(8):1162-1173.e8. PubMed ID: 23911260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations.
    Rampersaud E; Damcott CM; Fu M; Shen H; McArdle P; Shi X; Shelton J; Yin J; Chang YP; Ott SH; Zhang L; Zhao Y; Mitchell BD; O'Connell J; Shuldiner AR
    Diabetes; 2007 Dec; 56(12):3053-62. PubMed ID: 17846126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.
    Raskin P
    Diabetes Metab Res Rev; 2013 Jul; 29(5):347-56. PubMed ID: 23463735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of SNP276 in adiponectin gene with type 2 diabetes mellitus and insulin sensitivity].
    Ru Y; Ma M; Ma T; Wang CJ; Wang YM; Zhang Q; Chen MW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):698-701. PubMed ID: 16331577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus.
    Misra M
    J Pharm Pharmacol; 2013 Mar; 65(3):317-27. PubMed ID: 23356840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin.
    Sauber J; Grothe J; Behm M; Scherag A; Grallert H; Illig T; Hinney A; Hebebrand J; Wiegand S; Grüters A; Krude H; Biebermann H
    Eur J Endocrinol; 2010 Aug; 163(2):259-64. PubMed ID: 20516203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.